181 related articles for article (PubMed ID: 9766316)
21. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.
Nilaver G; Muldoon LL; Kroll RA; Pagel MA; Breakefield XO; Davidson BL; Neuwelt EA
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9829-33. PubMed ID: 7568227
[TBL] [Abstract][Full Text] [Related]
22. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.
Bartus RT; Elliott PJ; Dean RL; Hayward NJ; Nagle TL; Huff MR; Snodgrass PA; Blunt DG
Exp Neurol; 1996 Nov; 142(1):14-28. PubMed ID: 8912895
[TBL] [Abstract][Full Text] [Related]
23. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Dean RL; Emerich DF; Hasler BP; Bartus RT
Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
[TBL] [Abstract][Full Text] [Related]
24. Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
Remsen LG; McCormick CI; Sexton G; Pearse HD; Garcia R; Neuwelt EA
Clin Cancer Res; 1995 Jul; 1(7):731-9. PubMed ID: 9816039
[TBL] [Abstract][Full Text] [Related]
25. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
26. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
27. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
28. Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.
Sarin H; Kanevsky AS; Fung SH; Butman JA; Cox RW; Glen D; Reynolds R; Auh S
J Transl Med; 2009 May; 7():33. PubMed ID: 19439100
[TBL] [Abstract][Full Text] [Related]
29. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT
Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155
[TBL] [Abstract][Full Text] [Related]
30. Seizure-promoting effect of blood-brain barrier disruption.
Marchi N; Angelov L; Masaryk T; Fazio V; Granata T; Hernandez N; Hallene K; Diglaw T; Franic L; Najm I; Janigro D
Epilepsia; 2007 Apr; 48(4):732-42. PubMed ID: 17319915
[TBL] [Abstract][Full Text] [Related]
31. Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.
Liu R; Martuza RL; Rabkin SD
Gene Ther; 2005 Apr; 12(8):647-54. PubMed ID: 15647762
[TBL] [Abstract][Full Text] [Related]
32. Effect of antigenic heterogeneity on the efficacy of enhanced delivery of antibody-targeted chemotherapy in a human lung cancer intracerebral xenograft model in rats.
Muldoon LL
Neurosurgery; 2003 Dec; 53(6):1406-12; discussion 1412-3. PubMed ID: 14633307
[TBL] [Abstract][Full Text] [Related]
33. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
Nomura T; Inamura T; Black KL
Brain Res; 1994 Oct; 659(1-2):62-6. PubMed ID: 7529648
[TBL] [Abstract][Full Text] [Related]
34. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
35. Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
Hall WA; Doolittle ND; Daman M; Bruns PK; Muldoon L; Fortin D; Neuwelt EA
J Neurooncol; 2006 May; 77(3):279-84. PubMed ID: 16314949
[TBL] [Abstract][Full Text] [Related]
36. Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor.
Inoue T; Fukui M; Nishio S; Kitamura K; Nagara H
J Neurosurg; 1987 Feb; 66(2):256-63. PubMed ID: 3100731
[TBL] [Abstract][Full Text] [Related]
37. Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms.
Rainov NG; Zimmer C; Chase M; Kramm CM; Chiocca EA; Weissleder R; Breakefield XO
Hum Gene Ther; 1995 Dec; 6(12):1543-52. PubMed ID: 8664379
[TBL] [Abstract][Full Text] [Related]
38. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
39. Increased delivery of a new cisplatin analogue (254-S) in a rat brain tumor by an intracarotid infusion of bradykinin.
Koga H; Inamura T; Ikezaki K; Nomura T; Samoto K; Fukui M
Neurol Res; 1996 Jun; 18(3):244-7. PubMed ID: 8837061
[TBL] [Abstract][Full Text] [Related]
40. The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas.
Nakagawa H; Groothuis D; Blasberg RG
Neurology; 1984 Dec; 34(12):1571-81. PubMed ID: 6504329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
